Notice: This company has been marked as potentially delisted and may not be actively trading. Immuron (IMRN) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsCompetitorsHeadlinesShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Immuron Limited Sponsored ADRJanuary 18, 2025 | cnn.comImmuron reports strong sales growth of TravelanJanuary 17, 2025 | markets.businessinsider.comImmuron reports strong sales growth for TravelanJanuary 17, 2025 | msn.comImmuron Travelan® continued strong sales growthJanuary 17, 2025 | globenewswire.comImmuron Limited Issues New Ordinary Shares Complying with Legal StandardsJanuary 16, 2025 | tipranks.comImmuron Limited Applies for Quotation of New SecuritiesJanuary 16, 2025 | tipranks.comImmuron announces research collaboration agreement with Monash UniversityJanuary 15, 2025 | markets.businessinsider.comImmuron Announces New Research Collaboration targeting Antimicrobial ResistanceJanuary 15, 2025 | globenewswire.comImmuron Limited Announces Proposed Issue of SecuritiesJanuary 14, 2025 | tipranks.comImmuron announces Travelan clinical trial updateJanuary 14, 2025 | markets.businessinsider.comImmuron Partners with Monash University to Combat Antimicrobial ResistanceJanuary 14, 2025 | tipranks.comImmuron Announces Travelan® Clinical Trial UpdateJanuary 14, 2025 | globenewswire.comImmuron progresses development of traveller's diarrhea drug TravelanJanuary 14, 2025 | msn.comImmuron Submits Positive Travelan® Phase 2 Study Results to FDAJanuary 13, 2025 | tipranks.comImmuron Limited Quotation of New Securities on ASXJanuary 9, 2025 | tipranks.comImmuron Limited Announces Proposed Securities IssueJanuary 7, 2025 | tipranks.comImmuron Limited Issues New Unquoted Equity SecuritiesDecember 9, 2024 | tipranks.comImmuron Limited Director Acquires 1,000,000 OptionsDecember 9, 2024 | tipranks.comImmuron Limited Director Increases Stake with New OptionsDecember 9, 2024 | tipranks.comImmuron Limited Director Acquires Unlisted OptionsDecember 9, 2024 | tipranks.comImmuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5thDecember 2, 2024 | globenewswire.comImmuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap EventNovember 22, 2024 | finance.yahoo.comImmuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap EventNovember 21, 2024 | globenewswire.comImmuron Limited Secures Approval on Key AGM ResolutionsNovember 18, 2024 | markets.businessinsider.comImmuron Limited Issues New Unquoted Performance RightsOctober 29, 2024 | markets.businessinsider.comImmuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare ConferenceOctober 16, 2024 | globenewswire.comImmuron Limited: Immuron Travelan continued strong sales growthOctober 15, 2024 | finanznachrichten.deImmuron Travelan® continued strong sales growthOctober 15, 2024 | globenewswire.comImmuron turns in strong performance for Travelan® in September quarter, expands globallyOctober 14, 2024 | au.investing.comImmuron making inroads into the international market with flagship assets Travelan and IMM-529October 11, 2024 | au.investing.comImmuron (NASDAQ:IMRN) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comNMRC Reports Results for Campylobacter Controlled Human Infection Model StudyOctober 4, 2024 | globenewswire.comTraveler's Diarrhea Therapeutics Pipeline Market Report 2024 Featuring Immuron, Scandinavian Biopharma, and Sigmoid PharmaSeptember 19, 2024 | globenewswire.comImmuron Plans Phase 2 Trial for IMM-529 following FDA reviewSeptember 5, 2024 | globenewswire.comImmuron Limited (IMRN) Stock Price, News, Quote & History - Yahoo FinanceAugust 30, 2024 | ca.finance.yahoo.comImmuron Limited (IMRN)August 25, 2024 | finance.yahoo.comImmuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®August 16, 2024 | globenewswire.comBond investing making a comeback on rate cut forecasts: PanelAugust 16, 2024 | uk.finance.yahoo.comAI is being 'built into everything we're doing': Lenovo execAugust 16, 2024 | uk.finance.yahoo.comImmuron CEO, Steven Lydeamore to present at the Emerging Growth ConferenceAugust 15, 2024 | globenewswire.comImmuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct ConnectAugust 7, 2024 | globenewswire.comImmuron Limited (IMC.AX)August 4, 2024 | finance.yahoo.comImmuron requests pre-IND meeting for IMM-529 with FDA filingJuly 2, 2024 | globenewswire.comImmuron CEO, Steven Lydeamore to present at the Emerging Growth ConferenceJune 5, 2024 | globenewswire.comImmuron CEO Steven Lydeamore to present at Peak Sky HighMay 31, 2024 | globenewswire.comImmuron Board ChangesMay 31, 2024 | globenewswire.comImmuron Limited to Present at the Emerging Growth ConferenceMay 7, 2024 | globenewswire.comImmuron Director ResignationMay 3, 2024 | globenewswire.comImmuron Limited (IMRN) Interactive Stock Chart - Yahoo FinanceApril 15, 2024 | finance.yahoo.comImmuron to host Live Virtual EventApril 15, 2024 | globenewswire.com Get Immuron News Delivered to You Automatically Sign up to receive the latest news and ratings for IMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address IMRN Media Mentions By Week IMRN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMRN News Sentiment▼0.000.74▲Average Medical News Sentiment IMRN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMRN Articles This Week▼21▲IMRN Articles Average Week Get Immuron News Delivered to You Automatically Sign up to receive the latest news and ratings for IMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FBIO News Today LTRN News Today FGEN News Today RPTX News Today SPRO News Today KZR News Today VTVT News Today ALRN News Today ANEB News Today ITRM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMRN) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredTrump’s back in the oval office. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. And he says 2025 could be...Weiss Ratings | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immuron Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Immuron With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
